title: Life-threatening pseudophaeochromocytoma after toloxatone, terbutaline, and phenylephrine.
authors.forename: H
authors.initials: H
authors.lastname: Lefebvre
authors.forename: R
authors.initials: R
authors.lastname: Richard
authors.forename: C
authors.initials: C
authors.lastname: Noblet
authors.forename: N
authors.initials: N
authors.lastname: Moore
authors.forename: L M
authors.initials: LM
authors.lastname: Wolf
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000175:diagnosis*; D000368:Aged; D002395:Catecholamines / Q000378:metabolism; D003937:Diagnosis, Differential; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D010080:Oxazoles / Q000009:adverse effects*; D023303:Oxazolidinones; D010656:Phenylephrine / Q000009:adverse effects*; D010673:Pheochromocytoma / Q000175:diagnosis*; D013726:Terbutaline / Q000009:adverse effects*; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D023303:Oxazolidinones; D010656:Phenylephrine; C010798:toloxatone; D013726:Terbutaline